Kineta is committed to forging collaborations that will accelerate the development of novel antiviral therapies and vaccines to improve human health throughout the world, particularly in developing countries with high unmet needs. We aim to work closely with academic collaborators, global health organizations, governments and industry partners. These strategic alliances can deliver an extraordinary multiplier effect to our research and development efforts. Working together will accelerate the availability of novel antivirals and vaccine adjuvants to address unmet needs across the globe.